Yüklüyor......
A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
Tumor‐induced osteomalacia (TIO) is a rare cause of impaired bone mineralization mediated by the osteocyte‐derived, phosphaturic hormone: fibroblast growth factor 23 (FGF23). The case is presented of a previously healthy 45‐year‐old man who developed fragility fractures at multiple sites (initially...
Kaydedildi:
| Yayımlandı: | JBMR Plus |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872335/ https://ncbi.nlm.nih.gov/pubmed/33615107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10438 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|